RecruitingNot Applicable

Self-sampling for Non-attenders to Cervical Cancer Screening

Czechia15,000 participantsStarted 2019-09-23

Plain-language summary

The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.

Who can participate

Age range30 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with age 30-65 years; for arm A women \> 65 years are allowed * Women live in the Czech Republic. * Women who have not participate in cervical cancer screening program in the Czech Republic for at least 3 years (Arm B and C). * Women with completed informed consent. * Women capable of self-sampling of cervicovaginal swab. Exclusion Criteria: * Pregnant women. * Women with no sexual intercourse experience. * Women after hysterectomy including cervix.

What they're measuring

Screening participation

Timeframe: 12 months

Prevalence of high-risk HPV

Timeframe: 12 months

Trial details

NCT IDNCT04226313

SponsorThe Institute of Molecular and Translational Medicine, Czech Republic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

Contact for this trial

Marian Hajduch, MD, PhD.

+420 585 632 083 marian.hajduch@upol.cz

View on ClinicalTrials.gov More Cervical Cancer trials